| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,957 | 19,064 | 23,979 | 32,811 | | Cost of Revenue | (6,843) | 3,267 | 3,576 | 4,215 | | | Gross Profit | 31,800 | 15,797 | 20,403 | 28,596 | | | Operating Expenses | | Research Development | 132,132 | 139,331 | 143,581 | 144,610 | | Selling General and Administrative | 36,572 | 32,526 | 28,520 | 24,208 | | Non Recurring | 11,329 | 1,107 | 10,195 | 1,641 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (148,233) | (157,167) | (161,893) | (141,863) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 595 | (10,805) | 2,599 | 3,443 | | Earnings Before Interest And Taxes | (147,638) | (167,972) | (159,294) | (138,420) | | Interest Expense | 1,927 | 3,325 | 3,378 | 3,912 | | Income Before Tax | (149,565) | (171,297) | (162,672) | (142,332) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (149,565) | (171,297) | (162,672) | (142,332) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (149,565) | (171,297) | (162,672) | (142,332) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($149,565) | ($171,297) | ($162,672) | ($142,332) |
|
0.51% Nasdaq 
Income Statement
